Dearborn Partners LLC Makes New $20.48 Million Investment in Stryker Corporation $SYK

Dearborn Partners LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK) in the second quarter, HoldingsChannel.com reports. The firm acquired 65,038 shares of the medical technology company’s stock, valued at approximately $20,476,000.

Other large investors have also bought and sold shares of the company. Sankala Group LLC purchased a new position in Stryker in the 4th quarter worth approximately $26,000. Godfrey Financial Associates Inc. bought a new stake in shares of Stryker in the 4th quarter worth $26,000. United Financial Planning Group LLC bought a new stake in shares of Stryker in the 3rd quarter worth $27,000. Atlas Capital Advisors Inc. purchased a new position in shares of Stryker in the fourth quarter worth $27,000. Finally, Gables Capital Management Inc. bought a new position in shares of Stryker during the second quarter valued at $25,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on SYK. BTIG Research lowered their target price on shares of Stryker from $371.00 to $358.00 and set a “buy” rating on the stock in a research note on Friday, July 31st. Evercore set a $350.00 price target on shares of Stryker in a research note on Monday, July 6th. Wolfe Research cut shares of Stryker from an “outperform” rating to a “peer perform” rating in a report on Thursday, August 13th. The Goldman Sachs Group restated a “neutral” rating and set a $361.00 price objective on shares of Stryker in a research report on Friday, May 1st. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stryker in a research report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Stryker Price Performance

Shares of Stryker stock opened at $322.20 on Friday. The stock has a market cap of $123.58 billion, a P/E ratio of 33.39, a P/E/G ratio of 2.10 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The stock’s fifty day moving average is $328.64 and its 200 day moving average is $331.47. Stryker Corporation has a one year low of $281.00 and a one year high of $396.86.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.49 by $0.20. The business had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.Stryker’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Sell-side analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker’s payout ratio is 36.48%.

Insider Buying and Selling

In other Stryker news, insider Dylan Bram Crotty sold 441 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the transaction, the insider directly owned 6,102 shares in the company, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the sale, the insider directly owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 351,267 shares of company stock valued at $118,197,701. 4.60% of the stock is owned by corporate insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.